Glenwood, IL, United States of America

Paul H Rudolph


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul H Rudolph: Innovator in Periodontal Disease Detection

Introduction

Paul H Rudolph is a notable inventor based in Glenwood, IL (US). He has made significant contributions to the field of dental health, particularly in the detection of periodontal disease. His innovative approach has the potential to improve diagnostic methods in dentistry.

Latest Patents

Rudolph holds a patent for a "Method for detection of periodontal disease." This patent discloses improvements in methods for determining the presence of suprathreshold amounts of aspartate aminotransferase in an oral fluid sample. The method involves incubating aspartate aminotransferase substrate materials with the sample to form a first reaction product. Subsequently, the detection of this reaction product is achieved by incubating with an indicator substance, resulting in a second colored reaction product. The improvement includes utilizing a diazonium dyestuff as the indicator substance and modifying reaction conditions to ensure that no visually detectable colored reaction product is formed by subthreshold levels of aspartate aminotransferase.

Career Highlights

Rudolph's career is marked by his dedication to advancing dental diagnostics. His work at Xytronyx, Inc. has allowed him to focus on innovative solutions that address critical health issues. His patent reflects his commitment to enhancing the accuracy of periodontal disease detection.

Collaborations

Rudolph has collaborated with notable colleagues, including Scott D Babler and Peter Baram. These partnerships have contributed to the development and refinement of his innovative methods.

Conclusion

Paul H Rudolph's contributions to the field of periodontal disease detection exemplify the impact of innovation in healthcare. His patent and work at Xytronyx, Inc. highlight the importance of advancing diagnostic methods for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…